Okada M - Search Results

1

Domatinostat Targets the FOXM1-Survivin Axis to Reduce the Viability of Ovarian Cancer Cells Alone and in Combination with Chemotherapeutic Agents.

Nakagawa-Saito Y, Mitobe Y, Suzuki S, Togashi K, Sugai A, Kitanaka C, Okada M. Nakagawa-Saito Y, et al. Among authors: okada m. Int J Mol Sci. 2023 Jun 28;24(13):10817. doi: 10.3390/ijms241310817. Int J Mol Sci. 2023. PMID: 37445993 Free PMC article.

2

Targeting JNK for therapeutic depletion of stem-like glioblastoma cells.

Matsuda K, Sato A, Okada M, Shibuya K, Seino S, Suzuki K, Watanabe E, Narita Y, Shibui S, Kayama T, Kitanaka C. Matsuda K, et al. Among authors: okada m. Sci Rep. 2012;2:516. doi: 10.1038/srep00516. Epub 2012 Jul 19. Sci Rep. 2012. PMID: 22816039 Free PMC article.

3

Glioma-initiating cell elimination by metformin activation of FOXO3 via AMPK.

Sato A, Sunayama J, Okada M, Watanabe E, Seino S, Shibuya K, Suzuki K, Narita Y, Shibui S, Kayama T, Kitanaka C. Sato A, et al. Among authors: okada m. Stem Cells Transl Med. 2012 Nov;1(11):811-24. doi: 10.5966/sctm.2012-0058. Epub 2012 Nov 15. Stem Cells Transl Med. 2012. PMID: 23197693 Free PMC article.

4

Cytoplasmic localization of DGKζ exerts a protective effect against p53-mediated cytotoxicity.

Tanaka T, Okada M, Hozumi Y, Tachibana K, Kitanaka C, Hamamoto Y, Martelli AM, Topham MK, Iino M, Goto K. Tanaka T, et al. Among authors: okada m. J Cell Sci. 2013 Jul 1;126(Pt 13):2785-97. doi: 10.1242/jcs.118711. Epub 2013 Apr 19. J Cell Sci. 2013. PMID: 23606744

5

Resveratrol promotes proteasome-dependent degradation of Nanog via p53 activation and induces differentiation of glioma stem cells.

Sato A, Okada M, Shibuya K, Watanabe E, Seino S, Suzuki K, Narita Y, Shibui S, Kayama T, Kitanaka C. Sato A, et al. Among authors: okada m. Stem Cell Res. 2013 Jul;11(1):601-10. doi: 10.1016/j.scr.2013.04.004. Epub 2013 Apr 11. Stem Cell Res. 2013. PMID: 23651583 Free article.

6

Specific role of JNK in the maintenance of the tumor-initiating capacity of A549 human non-small cell lung cancer cells.

Okada M, Shibuya K, Sato A, Seino S, Watanabe E, Suzuki S, Seino M, Kitanaka C. Okada M, et al. Oncol Rep. 2013 Oct;30(4):1957-64. doi: 10.3892/or.2013.2655. Epub 2013 Aug 2. Oncol Rep. 2013. PMID: 23912840

7

Pivotal role for ROS activation of p38 MAPK in the control of differentiation and tumor-initiating capacity of glioma-initiating cells.

Sato A, Okada M, Shibuya K, Watanabe E, Seino S, Narita Y, Shibui S, Kayama T, Kitanaka C. Sato A, et al. Among authors: okada m. Stem Cell Res. 2014 Jan;12(1):119-31. doi: 10.1016/j.scr.2013.09.012. Epub 2013 Oct 4. Stem Cell Res. 2014. PMID: 24185179 Free article.

8

JNK contributes to temozolomide resistance of stem-like glioblastoma cells via regulation of MGMT expression.

Okada M, Sato A, Shibuya K, Watanabe E, Seino S, Suzuki S, Seino M, Narita Y, Shibui S, Kayama T, Kitanaka C. Okada M, et al. Int J Oncol. 2014 Feb;44(2):591-9. doi: 10.3892/ijo.2013.2209. Epub 2013 Dec 5. Int J Oncol. 2014. PMID: 24316756

9

JNK Signaling in the Control of the Tumor-Initiating Capacity Associated with Cancer Stem Cells.

Kitanaka C, Sato A, Okada M. Kitanaka C, et al. Among authors: okada m. Genes Cancer. 2013 Sep;4(9-10):388-96. doi: 10.1177/1947601912474892. Genes Cancer. 2013. PMID: 24349636 Free PMC article. Review.

10

Targeting the K-Ras--JNK axis eliminates cancer stem-like cells and prevents pancreatic tumor formation.

Okada M, Shibuya K, Sato A, Seino S, Suzuki S, Seino M, Kitanaka C. Okada M, et al. Oncotarget. 2014 Jul 15;5(13):5100-12. doi: 10.18632/oncotarget.2087. Oncotarget. 2014. PMID: 24947996 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

6,083 results

Search Page

Filters